SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-083194
Filing Date
2020-03-24
Accepted
2020-03-24 07:37:05
Documents
3
Period of Report
2020-03-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d833117d8k.htm 8-K 21586
2 EX-99.1 d833117dex991.htm EX-99.1 9939
3 GRAPHIC g833117snap0006.jpg GRAPHIC 2794
  Complete submission text file 0001193125-20-083194.txt   36756
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 20736613
SIC: 2834 Pharmaceutical Preparations